# Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mechanisms-of-acquired-resistance-to-first-line-osimertinib-preliminary-data/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Suresh S. Ramalingam,Yi Cheng,C. Zhou,Y. Ohe,Fumio Imamura,Byoung Chul Cho,Meng‐Chih Lin,Margarita Majem,Riyaz Shah,Yuri Rukazenkov,A. Todd,Aleksandra Markovets,J. Carl Barrett,Juliann Chmielecki,Jhanelle E. Gray |
| Citations | 357 |
| DOI | 10.1093/annonc/mdy424.063 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy424.063/26141271/mdy424.063.pdf |
| OpenAlex ID | https://openalex.org/W2898171786 |
| Type | article |
| Year | 2018 |

## Paper authors

- [C. Zhou](https://scholariq.org/researchers/c-zhou/)
- [Jhanelle E. Gray](https://scholariq.org/researchers/jhanelle-e-gray/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.